Trials / Completed
CompletedNCT02860416
Additional Post Hoc Analysis and Clinical Data Collection
Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- ElMindA Ltd · Industry
- Sex
- All
- Age
- 8 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
Detailed description
To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™). The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
Conditions
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-09-01
- Completion
- 2018-10-01
- First posted
- 2016-08-09
- Last updated
- 2019-06-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02860416. Inclusion in this directory is not an endorsement.